Section of Endocrinology, Diabetes and Metabolism

Endocrinology, Diabetes and Metabolism Grand Rounds

Master
Content

Day: Every other Friday beginning in September
Time: Noon - 1 p.m.
Location: BCM Main Campus, TBA
Moderator/Organizer: Dr. Marco Marcelli

Content

2020-21 Endocrinology, Diabetes & Metabolism Grand Rounds

Date

Title of Presentation

Home Institution

Speaker

Sept. 4 Driving Atypical Diabetes Baylor College of Medicine Dr. Balasubramanyam
Sept. 18

Bone Quality in Obese Women with Type 2 Diabetes and RADIANT: A Look at Atypical Diabetes

Baylor College of Medicine

Fellows Research Proposals

Oct. 9 Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Predictors of Glycemic Success in Sensor-Augmented Insulin Pump Therapy: A Retrospective Review of Patients at the Michael E. DeBakey VA Medical Center Baylor College of Medicine Fellows Research Proposals
Oct.. 30 Alpha-Cell to Beta-Cell Communication: A New Twist on the Incretin Effect Duke University Dr. Dave D'Alessio
Nov. 13 Approach to a patient with non-diabetic hypoglycemia Mayo Clinic Hospital Dr. Pankaj Shah
Dec. 11 Racial and Socioeconomic Disparities in the Incidence, Treatment and Treatment Response in Type 2 Diabetes Baylor College of Medicine Dr. Sara Cromer
Jan. 15 Glucose-Lowering Medications and CVD: Searching for the Holy Grail Yale University Dr. Silvio Inzucchi
Jan. 29 Post-Bariatric Hypoglycemia University of Colorado Hospital Dr. Helen Lawler 
Feb. 12 “Incretin-based therapies-how do they work?” Tanenbaum Research Institute, Mount Sinai Hospital Daniel J. Drucker
Feb. 26 Macrophages under pressure: novel roles in hypertension Washington University Dr. Carlos Bernal-Mizrachi
March 12 Targeting Cellular Senescence to Treat Age-Related Osteoporosis and Frailty Mayo Clinic College of Medicine Dr. Sundeep Khosla
March 26 Glucagon Revisited: Glycemic and Energetic Effects of Glucagon Receptor Agonism University of Alabama at Birmingham Dr. Kirk Habegger
April 9 Thyroid Nodules 2021: What to Do in an Era of Multiple Diagnostic Options University of Pennsylvania Dr. Susan Mandel
April 16 Primary Aldosteronism: Once a Zebra, Now a Horse Harvard University Medical School Dr. Anand Vaidya
April 23 2nd Year Fellow Research Presentation: Clinical Outcomes in Immune Checkpoint Inhibitor-Induced Diabetes Mellitus (RJ); "Hemoglobin A1c of 7% is the Threshold For Bone Impairment in Men With Type 2 Diabetes Mellitus". (SJ) Baylor College of Medicine Rebecca Jeun, M.D. & Sabaa Joab, M.D.
June 4 2nd Year Fellow Research Presentation Baylor College of Medicine Sara Ahmad, M.D. & Nupur Kikani, M.D.
       
Heading

Affiliates

Content

Affiliations with leading research and healthcare institutions in and around the Texas Medical Center, the world’s largest healthcare complex, provide access to an exceptionally diverse array of people and resources. Discover how our affiliations enhance our education programs.